Wolverine Trading’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-18,973
Closed -$959K 5471
2020
Q2
$649K Buy
+18,973
New +$555K ﹤0.01% 2456
2020
Q1
Sell
-18,282
Closed -$308K 5628
2019
Q4
$389K Sell
18,282
-33,537
-65% -$592K ﹤0.01% 3312
2019
Q3
$742K Buy
51,819
+13,937
+37% +$205K ﹤0.01% 2227
2019
Q2
$525K Sell
37,882
-10,578
-22% -$159K ﹤0.01% 2670
2019
Q1
$931K Sell
48,460
-85,966
-64% -$1.39M ﹤0.01% 2149
2018
Q4
$2.02M Buy
134,426
+31,849
+31% +$632K 0.01% 1405
2018
Q3
$2.14M Buy
102,577
+52,994
+107% +$1.26M ﹤0.01% 1607
2018
Q2
$724K Hold
49,583
﹤0.01% 2607
2018
Q1
$724K Buy
+49,583
New +$810K ﹤0.01% 2607
2016
Q3
Sell
-11,878
Closed -$33.2K 5312
2016
Q2
$27K Buy
+11,878
New +$39.7K ﹤0.01% 3881

Wolverine Trading's IMMU Position: Q3 2020 in Review

Wolverine Trading sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 18,973 shares — an estimated $959K sold.

Wolverine Trading first reported a position in IMMU in Q2 2016 and held it in 10 quarters. The position peaked at $2.14M in Q3 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Wolverine Trading reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Wolverine Trading sold 18,973 Immunomedics Inc shares in Q3 2020, an estimated $959K.
  • Wolverine Trading first reported a position in Immunomedics Inc in Q2 2016 and held it in 10 quarters.
  • Wolverine Trading's Immunomedics Inc position peaked at $2.14M in Q3 2018.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Wolverine Trading's 13F filing for Q3 2020, filed 13 Nov 2020.